Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SERENA: Ralfinamide in neuropathic low back pain
NCT01019824Phase 3Completed
- Sponsor
- Newron Pharmaceuticals
- Start
- Mar 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ralfinamide in neuropathic low back pain (NLBP), sponsored by Newron Pharmaceuticals. Started Mar 2009; status: completed.
02
Drugs
ralfinamide
03
Conditions
neuropathic low back pain (NLBP)
Beyond the preview
Go deeper on NCT01019824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01019824.